In one paragraphArticle in Pharmaceutics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
10 authors.
Kaito OhtaDepartment of Nuclear Medicine and Comprehensive Heart Failure Center (DZHI), University Hospital Würzburg, Oberdürrbacher Str. 6, 97080 Würzburg, Germany.
Hiroyuki KimuraAgency for Health, Safety and Environment, Kyoto University, Kyoto 606-8501, Japan.
Yusuke YagiFaculty of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama 700-8530, Japan.
Takanori SasakiFaculty of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama 700-8530, Japan.
Naoko NoseFaculty of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama 700-8530, Japan.
Masaru AkehiFaculty of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama 700-8530, Japan.
Tomohiko YamaneDepartment of Molecular Imaging Research, Kobe City Medical Center General Hospital, Kobe 650-0047, Japan.ORCID 0000-0003-0955-4272 Rudolf A WernerDepartment of Nuclear Medicine, LMU Hospital, and German Cancer Consortium (DKTK), Partner Site Munich, Ludwig-Maximilians-University of Munich, 80539 Munich, Germany.ORCID 0000-0003-3372-6046 Takahiro HiguchiDepartment of Nuclear Medicine and Comprehensive Heart Failure Center (DZHI), University Hospital Würzburg, Oberdürrbacher Str. 6, 97080 Würzburg, Germany.ORCID 0000-0001-9711-7835 Funding
Deutsche Forschungsgemeinschaft 424778381Deutsche Forschungsgemeinschaft 453989101Deutsche Forschungsgemeinschaft 507803309Japan Society for the Promotion of Science 23K24288Japan Society for the Promotion of Science JPMJSF2316
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
[18F]AF78[18F]fluproxadinenorepinephrine transporterpositron emission tomographyradiolabeling
Identifiers
PMID41599230
PMCPMC12844956
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390